Curcumin/Gd loaded apoferritin: A novel "theranostic" agent to prevent hepatocellular damage in toxic induced acute hepatitis

Molecular Pharmaceutics

Volumn 10, Issue 5, 2013, Pages 2079-2085

  Cutrin, Juan Carlos ^a,b   Crich, Simonetta Geninatti ^a   Burghelea, Diana ^a   Dastrù, Walter ^a   Aime, Silvio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

apoferritin; curcumin; Gd(III); hepatitis; MRI

Indexed keywords

ALANINE AMINOTRANSFERASE; APOFERRITIN; CURCUMIN; GADOTERIDOL; THIOACETAMIDE; TILETAMINE PLUS ZOLAZEPAM; XYLAZINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CONTRAST MEDIUM; DRUG CARRIER; GADOLINIUM; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENCAPSULATION; ENZYME ACTIVITY; LIVER CELL DAMAGE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TOXIC INDUCED ACUTE HEPATITIS; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DRUG-INDUCED LIVER INJURY; ENZYMOLOGY; PATHOLOGY; TOXICITY;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOFERRITINS; CONTRAST MEDIA; CURCUMIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG-INDUCED LIVER INJURY; GADOLINIUM; HETEROCYCLIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; ORGANOMETALLIC COMPOUNDS; THIOACETAMIDE;

EID: 84877260961     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3006177     Document Type: Article

References (32)

1. Geninatti Crich, S.; Cutrin, J. C.; Lanzardo, S.; Conti, L.; Kálmán, F. K.; Szabó, I.; Lago, N. R.; Iolascon, A.; Aime, S. Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model Contrast Media Mol. Imag. 2012, 7 (2) 81-8
2. Huang, J.; Zheng, D. L.; Qin, F. S.; Cheng, N.; Chen, H.; Wan, B. B.; Wang, Y. P.; Xiao, H. S.; Han, Z. G. Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling J. Clin. Invest. 2010, 120, 223-41
3. Makino, A.; Harada, H.; Okada, T.; Kimura, H.; Amano, H.; Saji, H.; Hiraoka, M.; Kimura, S. Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agent Nanomed. Nanotechnol. Biol. Med. 2011, 7, 638-646
4. Aime, S.; Frullano, L.; Geninatti Crich, S. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging Angew. Chem., Int. Ed. Engl. 2002, 41, 1017-9
5. Geninatti Crich, S.; Bussolati, B.; Tei, L.; Grange, C.; Esposito, G.; Lanzardo, S.; Camussi, G.; Aime, S. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe Cancer Res. 2006, 66, 9196-201
6. Lammers, T.; Rizzo, L. Y.; Storm, G.; Kiessling, F. Personalized nanomedicine Clin. Cancer Res. 2012, 15, 4889-94
7. Lammers, T.; Aime, S.; Hennink, W. E.; Storm, G.; Kiessling, F. Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 1029-38
8. Lammers, T.; Kiessling, F.; Hennink, W. E.; Storm, G. Nanotheranostics and image-guided drug delivery: current concepts and future directions Mol. Pharmaceutics 2010, 7, 1899-912
9. Janib, S. M.; Moses, A. S.; MacKay, J. A. Imaging and drug delivery using theranostic nanoparticles Adv. Drug Delivery Rev. 2010, 62, 1052-63
10. Rivera-Espinoza, Y.; Muriel, P. Pharmacological actions of curcumin in liver diseases or damage Liver Int. 2009, 29, 1457-1466
11. Shapiro, H.; Ashkenazi, M.; Weizman, N. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity J. Gastroenter. Hepatol. 2006, 21, 358-366
12. Reyes-Gordillo, K.; Segovia, J.; Shibayama, M. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress Fundam. Clin. Pharmacol. 2008, 22, 417-427
13. Shishodia, S.; Singh, T.; Chaturvedi, M. M. Modulation of transcription factors by curcumin Adv. Exp. Med. Biol. 2007, 595, 127-148
14. NCI Clinical development plan: curcumin J. Cell Biochem. 1996, 26S, 72-85
15. Zhang, F.; Koh, G. Y.; Jeansonne, D. P.; Hollingsworth, J. A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity J. Pharm. Sci. 2011, 100, 2778-89
16. Yallapu, M. M.; Jaggi, M.; Chauhan, S. C. Curcumin nanoformulations: a future nanomedicine for cancer Drug Discovery Today 2012, 17, 71-80
17. Basnet, P.; Hussain, H.; Tho, I.; Skalko-Basnet, N. Liposomal delivery system enhances anti-inflammatory properties of curcumin J. Pharm. Sci. 2012, 101, 598-609
18. Zebib, B.; Mouloungui, Z.; Noirot, V. Stabilization of curcumin by complexation with divalent cations in glycerol/water system Bioinorg. Chem. Appl. 2010, 2010, 292760
19. Vasalatiy, O.; Zhao, P.; Zhang, S.; Aime, S.; Sherry, A. D. Catalytic effects of apoferritin interior surface residues on water proton exchange in lanthanide complexes Contrast Media Mol. Imag. 2006, 1, 10-14
20. Fries, P. H.; Belorizky, E. Enhancement of the water proton relaxivity by trapping Gd3+ complexes in nanovesicles J. Chem. Phys. 2010, 133, 024504
21. Eder, M.; Butenandt, O.; Joster, R. Morphologic, histochemical and autoradiographic studies on acute and chronic thioacetamide poisoning Frankf Z. Pathol. 1965, 74, 599-619
22. Trennery, P. N.; Waring, R. H. Early changes in thioacetamide-induced liver damage Toxicol. Lett. 1983, 19, 299-307
23. Chilakapati, J.; Shankar, K.; Korrapati, M. C. Saturation toxicokinetics of thioacetamide: role in initiation of liver injury Drug Metab. Dispos. 2005, 33, 1877-1885
24. Park, J. H.; Kum, Y. S.; Lee, T. L. Melittin attenuates liver injury in thioacetamide-treated mice through modulating inflammation and fibrogenesis Exp. Biol. Med. (Maywood) 2011, 236, 1306-1313
25. Markman, M. Intraperitoneal antineoplastic drug delivery: rationale and results Lancet Oncol. 2003, 4, 277-283
26. Rice, D. W. Structural homology between mouse liver and horse spleen ferritins FEBS Lett. 1985, 181, 165-168
27. Eakins, M. N.; Eaton, S. M.; Fisco, R. A. Physicochemical properties, pharmacokinetics, and biodistribution of gadoteridol injection in rats and dogs Acad. Radiol. 1995, 2, 584-91
28. Deichmann, R.; Haase, A. Quantification of T1 values by SNAPSHOT-FLASH NMR Imaging J. Magn. Reson. 1992, 96, 608-612
29. Shiftan, L.; Israely, T.; Cohen, T.; Frydman, V.; Dafni, H.; Stern, R.; Neeman, M. Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma Cancer Res. 2005, 65, 10316-10323
30. Goel, A.; Kunnumakkara, A.; Aggrarwal, B. B. Curcumin as "Curecumin": from kitchen to clinic Biochem. Pharmacol. 2008, 75, 787-809
31. Kok, M. B.; Hak, S.; Mulder, W. J.; van der Schaft, D. W.; Strijkers, G. J.; Nicolay, K. Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T1 and T2 relaxivity Magn. Reson. Med. 2009, 61, 1022-32
32. Terreno, E.; Geninatti Crich, S.; Belfiore, S.; Biancone, L.; Cabella, C.; Esposito, G.; Manazza, A. D.; Aime, S. Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons Magn. Reson. Med. 2006, 55, 491-7